UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000008425
Receipt number	R000009910
Scientific Title	Phase II study of XELIRI and High-dose bevacizumab as second-line therapy in patients with metastatic colorectal cancer
Date of disclosure of the study information	2012/07/14
Last modified on	2012/07/13 12:55:22

---